KashifMMunirMD
Endocrinology • Baltimore, MDDiabetes, Lipid Metabolism, Thyroid
Associate Professor, Medicine, University of Maryland School of Medicine
Dr. Munir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Linden Ave
UM Center for Diabetes and Endocrinology
Baltimore, MD 21201Phone+1 443-682-6800Fax+1 410-856-3840
Summary
- Dr. Kashif Munir is an endocrinologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including University of Maryland Medical Center, Veterans Affairs Maryland Health Care System-Baltimore Division, University of Maryland Medical Center Midtown Campus, VA Maryland HC Syst-Baltimore, and University of Maryland Baltimore Washington Medical Center. He received his medical degree from Temple University School of Medicine and has been in practice 19 years. He specializes in diabetes, pituitary, and thyroid and is experienced in diabetes mellitus, diabetes mellitus tye 1, thyroid disease, and pituitary disease.
Education & Training
University of MarylandFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003- University of MarylandResidency, Internal Medicine, 1998 - 2001
Lewis Katz School of Medicine at Temple UniversityClass of 1998
Certifications & Licensure
MD State Medical License 2003 - 2025- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Diabetes Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- Effect of EGCG on the Body's Response to Insulin Start of enrollment: 2007 Feb 01
- Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease Start of enrollment: 2011 Nov 04
- An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. Start of enrollment: 2011 Aug 16
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsGlucagon-Like Peptide 1 Analogues as Adjunctive Therapy for Patients With Type 1 Diabetes: An Updated Systematic Review and Meta-analysis.Jeayoung Park, Spyridon Ntelis, Elvina Yunasan, Katherine D Downton, Terry Cheuk-Fung Yip
The Journal of Clinical Endocrinology and Metabolism. 2023-12-21 - 33 citationsContinuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial.Elias K Spanakis, Agustina Urrutia, Rodolfo J Galindo, Priyathama Vellanki, Alexandra L Migdal
Diabetes Care. 2022-10-01 - 10 citationsMetformin and Androgen Receptor-Axis-Targeted (ARAT) Agents Induce Two PARP-1-Dependent Cell Death Pathways in Androgen-Sensitive Human Prostate Cancer Cells.Yi Xie, Linbo Wang, Mohammad Afnan Khan, Anne W. Hamburger, Wei Guang
Cancers. 2021-02-05
Press Mentions
Older Adults with Hypothyroidism Face Elevated Risk of DeathDecember 12th, 2019
Hypothyroidism in Elderly Patients Linked to Increased Mortality RiskDecember 12th, 2019
FDA Panel Rejects New Empagliflozin Indication ForNovember 13th, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
